Zobrazeno 1 - 10
of 162
pro vyhledávání: '"timolol fixed combination"'
Publikováno v:
International Journal of Biomedicine, Vol 14, Iss 4, Pp 621-625 (2024)
Background: Glaucoma is a progressive disease that requires lifelong treatment to maintain visual function. Elevated intraocular pressure (IOP) is considered the most important treatable risk factor for disease development and progression. The presen
Externí odkaz:
https://doaj.org/article/269edb45892b4643b624f7c298341c93
Publikováno v:
Clinical Ophthalmology, Vol Volume 18, Pp 1751-1760 (2024)
Francesco Oddone,1 Lucia Tanga,1 Sara Giammaria,1 Lorenzo Sabbatini,2 Alfonso Strianese,2 Manuela Ferrazza,1 Luca Mario Rossetti2 1IRCCS - Fondazione Bietti, Rome, Italy; 2Eye Clinic, ASST Santi Paolo E Carlo, University of Milan, Milan, ItalyCorresp
Externí odkaz:
https://doaj.org/article/d9ed57df58ae4464a3a426a11b503879
Autor:
Inoue K, Kawashima T, Katakura S, Shidara K, Fujimoto T, Kohmoto H, Shiokawa M, Moriyama R, Okayama R
Publikováno v:
Clinical Ophthalmology, Vol Volume 12, Pp 549-554 (2018)
Kenji Inoue, Taku Kawashima, Seiki Katakura, Kyoko Shidara, Takayuki Fujimoto, Hiromi Kohmoto, Minako Shiokawa, Ryo Moriyama, Ryoko Okayama Inouye Eye Hospital, Tokyo, Japan Purpose: To evaluate the efficacy and safety of tafluprost/timolol fixed com
Externí odkaz:
https://doaj.org/article/a6552ab3288543888341d272a9db6b9b
Autor:
Okumichi H, Kiuchi Y, Baba T, Kanamoto T, Naito T, Nakakura S, Tabuchi H, Nii H, Sueoka C, Sugimoto Y
Publikováno v:
Clinical Ophthalmology, Vol Volume 11, Pp 1175-1181 (2017)
Hideaki Okumichi,1 Yoshiaki Kiuchi,1 Tetsuya Baba,2 Takashi Kanamoto,3 Tomoko Naito,4,5 Shunsuke Nakakura,6 Hitoshi Tabuchi,6 Hiroki Nii,7 Chie Sueoka,7 Yosuke Sugimoto1,8 1Department of Ophthalmology and Visual Science, Graduate School of Biomedical
Externí odkaz:
https://doaj.org/article/9c12189507f54285993c32dd6720882d
Publikováno v:
Clinical Ophthalmology, Vol Volume 11, Pp 55-61 (2016)
Tadashi Nakano,1 Shiro Mizoue,2 Nobuo Fuse,3 Aiko Iwase,4 Shun Matsumoto,5 Keiji Yoshikawa6 On behalf of the I.CHANGE2 study group 1Department of Ophthalmology, The Jikei University School of Medicine, Nishi-Shimbashi, Minato-ku, Tokyo, 2Department o
Externí odkaz:
https://doaj.org/article/9fd585c453a741dd991436fedbe8e671
Publikováno v:
Journal of Drug Assessment
article-version (VoR) Version of Record
article-version (VoR) Version of Record
Objective This study aimed to compare the therapeutic efficacy and safety of dorzolamide/timolol fixed-combination(Cosopt) in newly diagnosed primary open-angle glaucoma (POAG) patients. Methods In this prospective, interventional case series, newly
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hannu Uusitalo, Norbert Pfeiffer, Miguel A. Teus, Leopold Schmetterer, Luciano Quaranta, Andreas Katsanos, Gábor Holló, Cindy M.L. Hutnik, L. Jay Katz, Anastasios G. P. Konstas
Publikováno v:
Advances in Therapy
The key clinical attributes of preserved dorzolamide/timolol fixed combination (DTFC) and the emerging potential of preservative-free (PF) DTFC are reviewed with published evidence and clinical experience. The indications and role of DTFC in current
Publikováno v:
The Open Ophthalmology Journal
Background: The Tafluprost/Timolol Fixed Combination (TTFC) has demonstrated efficacy and safety in reducing Intraocular Pressure (IOP). However, direct comparisons of switching from tafluprost to TTFC are limited. Objective: To investigate the effic